Büchner / Schellong / Hiddemann Acute Leukemias II

Prognostic Factors and Treatment Strategies
Erscheinungsjahr 2012
ISBN: 978-3-642-74643-7
Verlag: Springer
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, Band 33, 776 Seiten, eBook

Reihe: Haematology and Blood Transfusion Hämatologie und Bluttransfusion

Acute leukemia a quite homogenous disease failed to break through the sound barriere of when untreated reveals a substantial hetero unsatisfactory cure rates even in special sub geneity in its response to therapy. While cure groups. While new protocols including more is achieved in a certain proportion of pa effective supportive care show some increase tients other cases prove to be highly resis in the initial response rates and certain im tant. The curability is superior in acute provements in the long-term results, no ben lymphoblastic (ALL) than in acute myeloid eficial effect on the relapse rate during the (AML) leukemia and - within both type- first 1 Y2 years emerged from any of these higher in children as compared to adults. regimens. Thus, high chances for cure are The two age groups and cell types can be presently restricted to children with ALL further subdivided into prognostic groups and to lesser proportions children with by special diagnostic features. Thus, in AML and adults with ALL and AML.

Zielgruppe

Research

Autoren/Hrsg.

Büchner, Thomas

Schellong, Günther

Hiddemann, Wolfgang

Ritter, Jörg

Inhaltsverzeichnis

Leukemia Cell Biology and Basic Science.- Acute Myelogenous Leukemia in Children.- Acute Myelogenous Leukemia in Adults.- Acute Lymphoblastic Leukemia in Adults.- Acute Lymphoblastic Leukemia in Children.- Supportive Care in Acute Leukemias.- Treatment of Relapse and Pharmacokinetics.- Bone Marrow Transplantation.- Hematopoietic Growth Factors.